abstract |
2-arylthiazole compounds of formula (I), pharmaceutically acceptable salts and esters thereof, that are suitable as PPARalpha and PPARgamma agonists are disclosed, wherein R1 to R10, X, Y and n are as defined in the specification. These compounds are suitable for use in the treatment of diseases such as diabetes. |